All Stories

  1. Molecular Detection of Theileria ovis, Anaplasma ovis, and Rickettsia spp. in Rhipicephalus turanicus and Hyalomma anatolicum Collected from Sheep in Southern Xinjiang, China
  2. Dietary spirulina platensis a promising growth promotor and immune stimulant in broiler chickens
  3. In Vitro Activity and Atom Pair Fingerprint Analysis of Potent Hits from Malaria Box against Staphylococcus aureus Isolated from Cows with Clinical Mastitis
  4. Camellia sinensis Aqueous Extract: A Promising Candidate for Hepatic Eimeriosis Treatment in Rabbits
  5. Genetic Diversity of Merozoite Surface Antigens in Global Babesia bovis Populations
  6. Cross-sectional community-based study to assess the awareness of toxoplasmosis in Saudi Arabia
  7. Babesia microti alleviates disease manifestations caused by Plasmodium berghei ANKA in murine co-infection model of complicated malaria
  8. Diminazene aceturate and imidocarb dipropionate-based combination therapy for babesiosis – A new paradigm
  9. Evaluating the inhibitory effect of resveratrol on the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice
  10. Development of a promising antigenic cocktail for the global detection of Babesia caballi in horse by ELISA
  11. Global prevalence and species diversity of tick-borne pathogens in buffaloes worldwide: a systematic review and meta-analysis
  12. Gastrointestinal Parasites of Dogs in Egypt: An Update on the Prevalence in Dakahlia Governorate and a Meta-Analysis for the Published Data from the Country
  13. Imidazo[1,2-a]pyridine: a Highly Potent Therapeutic Agent Clears Piroplasm Infection In Vitro
  14. COVID-19 and Thymoquinone: Clinical Benefits, Cure, and Challenges
  15. In Vitro Inhibitory Effects and Bioinformatic Analysis of Norfloxacin and Ofloxacin on Piroplasm
  16. Molecular Investigation of Tick-Borne Haemoparasites Isolated from Indigenous Zebu Cattle in the Tanga Region, Tanzania
  17. The Potential Protective Effect and Underlying Mechanisms of Physiological Unconjugated Hyperbilirubinemia Mediated by UGT1A1 Antisense Oligonucleotide Therapy in a Mouse Model of Cyclosporine A-Induced Chronic Kidney Disease
  18. Ascorbic acid co-administration with a low dose of diminazene aceturate inhibits the in vitro growth of Theileria equi, and the in vivo growth of Babesia microti
  19. In vivo activity and atom pair fingerprint analysis of MMV665941 against the apicomplexan parasite Babesia microti, the causative agent of babesiosis in humans and rodents
  20. Efficacy of the Antimalarial MMV390048 against Babesia Infection Reveals Phosphatidylinositol 4-Kinase as a Druggable Target for Babesiosis
  21. Repurposing of the Malaria Box for Babesia microti in mice identifies novel active scaffolds against piroplasmosis
  22. Molecular Epidemiology and Species Diversity of Tick-Borne Pathogens of Animals in Egypt: A Systematic Review and Meta-Analysis
  23. Pomegranate (Punica granatum) Peel Inhibits the In Vitro and In Vivo Growth of Piroplasm Parasites
  24. Pycnogenol a promising remedy for diabetic keratopathy in experimentally induced corneal alkali burns in diabetic rats
  25. Abdominal Hernia in Equine: Animal Level Risk Factors and Repair Using Polypropylene Mesh
  26. MMV020275 and MMV020490, promising compounds from malaria box for the treatment of equine piroplasmosis
  27. Effect of methanolic extract from Capsicum annuum against the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice
  28. Identification and Characterization of P0 Protein as a Vaccine Candidate Against Babesia divergens, Blood Parasite of Veterinary and Zoonotic Importance
  29. Inhibitory effect of naphthoquine phosphate on Babesia gibsoni in vitro and Babesia rodhaini in vivo
  30. Evaluation of the in vitro and in vivo inhibitory effects of Artemisia herba-alba against the growth of piroplasm parasites
  31. Farm and animal levels risk factors associated with rectal prolapse in bovine and buffalo calves in Egypt with special reference to the optimal treatment strategy
  32. In vivo antibabesial activity and bioinformatic analysis of compounds derived from the Medicines for Malaria Venture box against Babesia microti
  33. In vitro screening of novel anti-Babesia gibsoni drugs from natural products
  34. Evaluation of the inhibitory effect of Zingiber officinale rhizome on Babesia and Theileria parasites
  35. Discovering the Potent Inhibitors Against Babesia bovis in vitro and Babesia microti in vivo by Repurposing the Natural Product Compounds
  36. Immunomodulatory Effect of Vitamin C on Proinflammatory Cytokines Production in Ossimi Lambs (Ovis aries) with Pneumonic Pasteurellosis
  37. Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of Babesia divergens, a Blood-Borne Parasite of Veterinary and Zoonotic Importance
  38. Phenytoin: A promising non-antibiotic drug for the topical treatment of digital dermatitis in dairy cows
  39. Effects of Methanolic Extract from Turmeric (Curcuma longa) against the In Vitro Multiplication of Several Babesia Species and Theileria equi
  40. Molecular detection of selected tick-borne pathogens infecting cattle at the wildlife–livestock interface of Queen Elizabeth National Park in Kasese District, Uganda
  41. Single nucleotide polymorphisms, gene expression and serum profile of immune and antioxidant markers associated with postpartum disorders susceptibility in Barki sheep
  42. Gene expression and serum profile of antioxidant markers discriminate periparturient period time in dromedary camels
  43. Impact of using pyronaridine tetraphosphate- based combination therapy in the treatment of babesiosis caused by Babesia bovis, B. caballi, and B. gibsoni in vitro and B. microti in mice
  44. GENETIC POLYMORPHISMS AND EXPRESSION PATTERN OF IGF-I GENE IN COMMERCIAL BROILER STRAINS
  45. Phylogenetic study of Theileria ovis and Theileria lestoquardi in sheep from Egypt: Molecular evidence and genetic characterization
  46. Molecular detection and identification of Babesia bovis and Trypanosoma spp. in one-humped camel (Camelus dromedarius) breeds in Egypt
  47. PLK:Δgra9 Live Attenuated Strain Induces Protective Immunity Against Acute and Chronic Toxoplasmosis
  48. Clinical Efficacy of Antimicrobial Agents in Combination with Flunixin Meglumine and Phenylbutazone on Acute Phase Response in Respiratory Disease of Calves
  49. Field Observations and Genetic Characterization of Sheep-Associated Malignant Catarrhal Fever in Egypt, 2018
  50. Molecular detection and characterization of tick-borne haemoparasites among cattle on Zanzibar Island, Tanzania
  51. Molecular Detection and Identification of Babesia spp., and Trypanosoma spp. in One-humped Camel (Camelus dromedarius) in Halayeb and Shalateen, Egypt
  52. First detection of Anaplasma ovis in sheep and Anaplasma platys-like variants from cattle in Menoufia governorate, Egypt
  53. Molecular Detection and Identification of Babesia spp., Theileria spp., and Anaplasma spp. in Sheep From Border Regions, Northwestern China
  54. Molecular detection of tick-borne pathogens harbored by ticks collected from livestock in the Xinjiang Uygur Autonomous Region, China
  55. An epidemiological survey of Theileria equi parasite in donkeys (Equus asinus) in Egypt
  56. Molecular Detection and Assessment of Risk Factors for Tick-Borne Diseases in Sheep and Goats from Turkey
  57. Closing the empty anti-Babesia gibsoni drug pipeline in vitro using fluorescence-based high throughput screening assay
  58. Current status of tropical theileriosis in Northern Africa: A review of recent epidemiological investigations and implications for control
  59. Assay methods for in vitro and in vivo anti-Babesia drug efficacy testing: Current progress, outlook, and challenges
  60. Drug screening of food and drug administration-approved compounds against Babesia bovis in vitro
  61. Myrrh Oil in Vitro Inhibitory Growth on Bovine and Equine Piroplasm Parasites and Babesia microti of Mice
  62. Transient Transfection of the Zoonotic Parasite Babesia microti
  63. Effect of prepartum vitamin E and selenium administration on postpartum gene expression and metabolic profile of immune and oxidative markers in Barki ewes
  64. Cocktail Babesia bovis antigens for global detection of Babesia bovis infection in cattle
  65. Discovering the in vitro potent inhibitors against Babesia and Theileria parasites by repurposing the Malaria Box: A review
  66. Honey inhibits the in vitro growth of four Babesia species and Theileria equi
  67. Screening the Medicines for Malaria Venture Pathogen Box against piroplasm parasites
  68. Antimicrobial resistance profiles and virulence genotyping of Salmonella enterica serovars recovered from broiler chickens and chicken carcasses in Egypt
  69. Evaluation of the in vitro and in vivo inhibitory effect of thymoquinone on piroplasm parasites
  70. Effects of supplementation of Bacillus spp. on blood metabolites, antioxidant status, and gene expression pattern of selective cytokines in growing Barki lambs
  71. Dietary flaxseed oil inhibits kidney NF-kappa B activation and pro-inflammatory cytokine expression in cisplatin-treated rats
  72. The first molecular detection of Clostridium perfringens from pneumonic cases associated with foot and mouth disease in cattle and buffalo in Egypt
  73. An epidemiological survey of bovine viral diarrhea infection in calves in Egypt with identification of high prevalence of persistent infected animals
  74. siRNA Blocking of Mammalian Target of Rapamycin (mTOR) Attenuates Pathology in Annonacin-Induced Tauopathy in Mice
  75. Comparative Effect of Intravenous Administration of Medetomidine, Tramadol, and Medetomidine/Tramadol Combination on Intraocular Pressure (IOP) in Clinically Healthy Donkeys (Equus asinus)
  76. Inhibitory effects of fluoroquinolone antibiotics on Babesia divergens and Babesia microti, blood parasites of veterinary and zoonotic importance
  77. Epidemiological study on tropical theileriosis (Theileria annulata infection) in the Egyptian Oases with special reference to the molecular characterization of Theileria spp
  78. Potential immune modulating properties and antioxidant activity of supplementing commercially available lactoferrin and/orLactobacillus sp. in healthy Ossimi lambs
  79. Animal-level risk factors associated with foot-and-mouth disease in cattle and buffalo in Egypt
  80. The effects of nitidine chloride and camptothecin on the growth of Babesia and Theileria parasites
  81. Molecular characterization of the vitamin D receptor (VDR) gene in Holstein cows
  82. Significance of selected biochemical markers in predicting the outcome of schistosomiasis
  83. 17-DMAG inhibits the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice
  84. Comparative clinical and parasitological efficacy of moxidectin pour-on, ivermectin, and piperazine citrate on Toxocara vitulorum infection in buffalo calves (Bubalus bubalis):a randomized clinical trial
  85. Molecular identification and antigenic characterization of Babesia divergens Erythrocyte Binding Protein (BdEBP) as a potential vaccine candidate
  86. Chemotherapeutic efficacies of a clofazimine and diminazene aceturate combination against piroplasm parasites and their AT-rich DNA-binding activity on Babesia bovis
  87. Performance and consistency of a fluorescence-based high-throughput screening assay for use in Babesia drug screening in mice
  88. Comparative therapeutic effect of steroidal and non-steroidal anti-inflammatory drugs on pro-inflammatory cytokine production in water buffalo calves (Bubalus bubalis) naturally infected with bronchopneumonia: a randomized clinical trial
  89. Evaluation of the inhibitory effect of N-acetyl-L-cysteine on Babesia and Theileria parasites
  90. Sepsis-Induced Acute Kidney Injury in Equine: Current Knowledge and Future Perspectives
  91. A comparative study on selected APP, alkaline phosphatase and lactate dehydrogenase activities in buffalo and cow with subclinical mastitis
  92. Animal level risk factors associated with Babesia and Theileria infections in cattle in Egypt
  93. Single Nucleotide Polymorphisms in IL8 and TLR4 Genes as Candidates for Digital Dermatitis Resistance/Susceptibility in Holstein Cattle
  94. Large-scale drug screening against Babesia divergens parasite using a fluorescence-based high-throughput screening assay
  95. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond
  96. Effects of Tilmicosin Phosphate Administration on Echocardiographic Parameters in Healthy Donkeys (Equus asinus): An Experimental Study
  97. Evaluation of in vitro inhibitory effect of enoxacin on Babesia and Theileria parasites
  98. Cocktail of Theileria equi antigens for detecting infection in equines
  99. Optimization of a Fluorescence-Based Assay for Large-Scale Drug Screening against Babesia and Theileria Parasites
  100. An epidemiological survey of bovine Babesia and Theileria parasites in cattle, buffaloes, and sheep in Egypt
  101. Evaluation of a Fluorescence-Based Method for Antibabesial Drug Screening
  102. A comparative study on selected acute-phase proteins (APPs) and immunoglobulins in buffalo and bovine calves with respiratory disease
  103. Effect of Selenium and Vitamin C on Clinical Outcomes, Trace Element Status, and Antioxidant Enzyme Activity in Horses with Acute and Chronic Lower Airway Disease. A Randomized Clinical Trial
  104. Antioxidant Trace Elements in Serum of Draft Horses with Acute and Chronic Lower Airway Disease
  105. Evaluation of indirect TaSP enzyme-linked immunosorbent assay for diagnosis of tropical theileriosis in cattle (Bos indicus) and water buffaloes (Bubalus bubalis) in Egypt
  106. Ketosis in buffalo (Bubalus bubalis): clinical findings and the associated oxidative stress level
  107. Evaluation of the in vitro growth-inhibitory effect of epoxomicin on Babesia parasites